Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development

476 indexed citations
published 2014

Countries where authors are citing Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development

Specialization
Citations

This map shows the geographic impact of Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development more than expected).

Fields of papers citing Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development.

About Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development

This paper, published in 2014, received 476 indexed citations . Written by Paresh Agarwal and Carolyn R. Bertozzi covering the research area of Oncology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Radiology, Nuclear Medicine and Imaging (319 citations), Molecular Biology (258 citations) and Oncology (237 citations). Published in Bioconjugate Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1021/bc5004982.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026